JP2001519326A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519326A5
JP2001519326A5 JP2000514880A JP2000514880A JP2001519326A5 JP 2001519326 A5 JP2001519326 A5 JP 2001519326A5 JP 2000514880 A JP2000514880 A JP 2000514880A JP 2000514880 A JP2000514880 A JP 2000514880A JP 2001519326 A5 JP2001519326 A5 JP 2001519326A5
Authority
JP
Japan
Prior art keywords
mol
hydrogen
aryl
sodium
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000514880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519326A (ja
JP4294217B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/020580 external-priority patent/WO1999018068A1/en
Publication of JP2001519326A publication Critical patent/JP2001519326A/ja
Publication of JP2001519326A5 publication Critical patent/JP2001519326A5/ja
Application granted granted Critical
Publication of JP4294217B2 publication Critical patent/JP4294217B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000514880A 1997-10-03 1998-10-01 スチリルスルホン抗癌剤 Expired - Fee Related JP4294217B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6093397P 1997-10-03 1997-10-03
US60/060,933 1997-10-03
PCT/US1998/020580 WO1999018068A1 (en) 1997-10-03 1998-10-01 Styryl sulfone anticancer agents

Publications (3)

Publication Number Publication Date
JP2001519326A JP2001519326A (ja) 2001-10-23
JP2001519326A5 true JP2001519326A5 (enExample) 2006-02-09
JP4294217B2 JP4294217B2 (ja) 2009-07-08

Family

ID=22032642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000514880A Expired - Fee Related JP4294217B2 (ja) 1997-10-03 1998-10-01 スチリルスルホン抗癌剤

Country Status (15)

Country Link
US (1) US6359013B1 (enExample)
EP (1) EP1027330B1 (enExample)
JP (1) JP4294217B2 (enExample)
KR (1) KR100579355B1 (enExample)
CN (1) CN1163480C (enExample)
AT (1) ATE284386T1 (enExample)
AU (1) AU741042B2 (enExample)
BR (1) BR9814059B1 (enExample)
CA (1) CA2305790C (enExample)
CZ (1) CZ299718B6 (enExample)
DE (1) DE69828079T2 (enExample)
IL (1) IL135438A (enExample)
NZ (1) NZ503479A (enExample)
RU (1) RU2201919C2 (enExample)
WO (1) WO1999018068A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6762207B1 (en) 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
AU774738B2 (en) * 1999-04-02 2004-07-08 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6656968B1 (en) 1999-06-16 2003-12-02 Temple University - Of The Commonwealth System Of Higher Education (Z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
US6767926B1 (en) 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
DE60044092D1 (de) * 1999-10-12 2010-05-12 Univ Temple Ungesättigte arylsulfone zum schutz von normalen zellen gegen die zytotoxische wirkung von chemotherapeutika
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
JP2004510761A (ja) 2000-10-05 2004-04-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性疾病を治療するための置換(e)−スチリルベンジルスルホン
CA2439256A1 (en) * 2001-02-27 2002-09-06 Temple University - Of The Commonwealth System Of Higher Education (z)-styrylbenzylsulfones and pharmaceutical uses thereof
DE60228692D1 (de) * 2001-02-28 2008-10-16 Univ Temple Verwendung von alpha, beta ungesättigten arylsulfonen zum schutz von zellen und geweben vor toxizität ionischer strahlung
EP1487428B1 (en) * 2002-02-28 2011-09-21 Temple University - Of The Commonwealth System of Higher Education Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
IL163608A0 (en) * 2002-02-28 2005-12-18 Univ Temple Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
US7012100B1 (en) * 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
AU2004289281C1 (en) * 2003-11-14 2011-12-08 Onconova Therapeutics, Inc. Alpha, beta-Unsaturated sulfoxides for treating proliferative disorders
EA200901236A1 (ru) 2004-03-16 2009-12-30 Темпл Юниверсити - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений
EP1773310B9 (en) 2004-06-24 2012-04-25 Temple University - Of The Commonwealth System of Higher Education Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
WO2006074149A2 (en) * 2005-01-05 2006-07-13 Temple University-Of The Commonwealth System Of Higher Education Treatment of drug-resistant proliferative disorders
AU2006216544B2 (en) * 2005-02-25 2012-04-05 Onconova Therapeutics, Inc. Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
WO2008027049A1 (en) 2006-08-30 2008-03-06 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
CA2663375A1 (en) * 2006-09-15 2008-03-20 Onconova Therapeutics, Inc. Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
WO2008076270A2 (en) * 2006-12-13 2008-06-26 Temple University-Of The Commonwealth System Of Higher Education Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
WO2014047110A2 (en) 2012-09-20 2014-03-27 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
EP2928456B1 (en) 2012-12-07 2021-02-03 Onconova Therapeutics, Inc. Treatment of hematological cancer refractory to an anti-cancer agent
WO2017023912A1 (en) 2015-08-03 2017-02-09 Temple University - Of The Commonwealth System Of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532612A (en) 1945-08-29 1950-12-05 Union Oil Co Preparation of unsaturated thio-ethers
US3185743A (en) 1960-08-24 1965-05-25 Union Carbide Corp Production of olefinic compounds from allyl sulfones
US3418101A (en) 1965-12-15 1968-12-24 Pennsalt Chemicals Corp Process for plant desiccation
US3514386A (en) 1967-12-11 1970-05-26 Exxon Research Engineering Co Stereoselective addition of thiols to acetylenic compounds
US3917714A (en) 1972-09-06 1975-11-04 American Cyanamid Co Bis(alkylsulfonyl)vinylbenzenes
US4161407A (en) 1977-10-06 1979-07-17 Eastman Kodak Company Crosslinkable polymers having vinylsulfonyl groups or styrylsulfonyl groups and their use as hardeners for gelatin
US4386221A (en) 1981-10-28 1983-05-31 Eastman Kodak Company Process for the preparation of aryl alkyl sulfones and aryl vinyl sulfones
US4937388A (en) * 1985-08-09 1990-06-26 Imperial Chemical Industries Plc Insecticidal ethers
FR2645536B1 (fr) * 1989-04-10 1991-05-31 Rhone Poulenc Agrochimie Composes herbicides et les compositions les contenant
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5659087A (en) 1995-06-07 1997-08-19 Eli Lilly And Company Diarylvinyl sulfoxides
WO1996040629A1 (en) * 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders

Similar Documents

Publication Publication Date Title
JP2001519326A5 (enExample)
EP1309547B1 (en) Crystalline and pure modafinil, and process of preparing the same
JP2001516338A (ja) マトリックスメタロプロテイナーゼ・インヒビターとしてのβ―スルホニルヒドロキサム酸
JP2002541101A5 (enExample)
IE911732A1 (en) Oxidant sensitive and insensitive aromatic esters as¹inhibitors of human neutrophil elastase
JP2005530795A (ja) ビカルタミドの製造方法
CN110655480B (zh) 一种砜类化合物的合成方法
WO1996019448A1 (en) Process for producing bis(4-alkylthiophenyl) disulfide
JP2008539163A (ja) ヒドラゾン類の製造法
JP3647812B2 (ja) 3−アリールサルファヒドロキサム酸の製造方法
Brown A convenient method for the preparation of (alkylsulfonyl) benzoic acids
EP0539451B1 (fr) Vinylsulfonyl pristinamycine et sa preparation
JP3159767B2 (ja) 新規な含硫黄化合物及びその製造方法
EP0675877A1 (en) A process for preparing sulfones
CN114989052B (zh) 一种愈创奥硫醚化合物及其制备方法
JPH0460975B2 (enExample)
JPH0723356B2 (ja) 4,4―ジスルホニルブタン酸エステル類の製造法
US20040106829A1 (en) Process for the synthesis of modafinil
JPS6361297B2 (enExample)
JP2001520220A (ja) S−(4−ビフェニル)−チオ硫酸及びその塩、その製造方法及び4−メルカプトビフェニルの製造
EP0539484B1 (fr) Procede de preparation de sulfonylpristinamycine iib
JP3942686B2 (ja) α−(アシルイミノ)−ベンジルスルホキシド又はα−(アシルイミノ)−ベンジルスルホン類
JPS5935380B2 (ja) フエニル酢酸誘導体及びその製造方法
JPS62298546A (ja) アニスアルデヒドの製造法
JPH041175A (ja) ジチオジプロピオン酸ジエステルの製造方法